Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07114224) titled 'Aß PET and Tau PET Imaging in the Diagnosis and Progression Assessment of Alzheimer's Disease' on Aug. 4.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Diagnostic. Masking: None (Open Label).
Primary Sponsor: Xijing Hospital
Condition:
Alzheimer Disease (AD)
Cognitive Dysfunction, Cognitive Disorder
PET Imaging
Intervention:
Diagnostic Test: AV45/AV-1?AV1451 PET
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: August 15, 2025
Target Sample Size: 70
To know more, visit https://clinicaltrials.gov/ct2/...